Bruce Campbell (2)

Inflation continues at a fairly high rate but there have been some price declines in some commodities, used car prices, shipping rates. The two biggest areas of inflation are food and shelter which will likely continue for some time. Consumer and business sentiment are at all-time lows which historically means that the market could be near the bottom. This could be considered a bright spot in the market turmoil. Feelings are very pessimistic everywhere which could mean a better second half. The short term investor should continue to trade the sell-offs and rallies, For longer term investors, one to two years, there is lots on sale.. Some strong companies are down 50, 60 or 70%. Investors can take advantage of the very negative mood in the market.

It is developing and building a plant based nutritional company. It had some challenges with getting products up and running. Pushing ahead with GNC and then Walmart. It also had products on Amazon but they sold out and will have to replenish. Not in Canada yet. One to watch - it is in the second inning and should go much higher over the years. Expect the business to be sold eventually.

With a one to two year time horizon it looks very attractive. It restructured and recently went public via SPAC which probably hurt the stock price. It is building an electric furnace which will boost output and be more efficient. It is trading at 1X which should be higher with a better economy in two years.

It specializes in biodegradable plant based products for packaging. The management team has done really well and has delivered exactly like they said. It is expecting 100% growth, 50% organically and 50% by acquisition, in fact it made one today. It is cross selling products as well as new products. It is part of the move away from using pure plastics for packaging. The stock got ahead of itself , has fallen back and you can expect it to do well. He doesn't own the stock itself but owns the debentures.

It is in Lithium in Saskatchewan. Very undervalued when compared to others. If and when it proves out their lithium brine and extraction technology it should do well.

It continues to be a real leader in the space since small and big businesses rely on them. The price got ahead of itself and so the multiples are much more attractive, but still quite high when compared to other sectors. He just added it to two portfolios recently after selling at about the $2000 mark. Continue to take bite sized pieces when opportunities arise.

Cannabis stocks sold off in the U.S. with many companies burning through cash. Curaleaf should continue to be a leader with cash on the balance sheet and generating cash. It is still building its business. There are challenges in the Cannabis market in the U.S. at the moment. Waiting for more legalization legislation.

(A Top Pick Sep 02/21, Down 50%) It is in the helium space and has the best well in North America. That one well when in a commercial state could be worth $1.95 in cash. Its business is better than ever. One analyst has a price target of $4.25 and another a target of $3.50.

(A Top Pick Sep 02/21, Down 30%) Health care is moving into homes so it is in a good spot. It is still making accretive acquisitions and guiding 30% higher revenue. It is in 19 states. He continues to hold the debentures.

(A Top Pick Sep 02/21, Down 61%) It is in the home monitoring business which could be huge one day. The business is operating well and signing up more patients. It receives around $50.00 per patient per month. It is a good time to buy now. A small cap.

The energy sector has come off in the past month but could stay fairly strong depending on the slow down in the economy. Trading is based on commodity prices. Wait for a pull back. Central banks in Asia are actually starting to cut rates to stimulate the economies.

The question was on Canadian banks. There are recession worries so the banks are trading at quite interesting yields, historically. He recently added BNS and BMO to the Income portfolio and will add more. With a long term horizon, 5 to 10 years you will have a great yield.

The Cannabis space has had its difficulties so Indiva has pivoted to a manufacturing company. It has done deals in the U.S. and is developing new products. Its products are popular but there was a recent hiccup involving deliveries. The full year should show better results. Eventually it should be taken out. He owns in the Cannabis portfolio.

The name of the company was indistinct and this is the closest result in the data base. It is a biotech company focused on brain health. It acquired an AI company called Metro Mark. It is signing more and more deals with pharmaceutical companies for up-front and royalty payments.

It continues to grow and execute and management has delivered, but the market isn't interested in this type of stock. It did a recent acquisition and financial raise. It is building a digital platform for doctors - patient records etc.